by rss feed | Feb 21, 2021 | Blog, brain stem cells, COVID-19, heart and stem cells, heart stem cell, News Feeds, NSC, Stem cells for COVID-19
There are weeks when it seems like papers on stem cells keep popping up. It can be a challenge to keep up with reading all the papers you want to read. Other times it is cell biology news that keeps breaking. The big news of the past week or so was unfortunately the...
by rss feed | Feb 10, 2021 | Blog, COVID-19, News Feeds, Science hype, stem cell hype, stem cells, Stem cells for COVID-19
At times there’s been seriously bad journalism covering COVID-19 itself including implications of various things being a COVID cure. Of course, media coverage of stem cell research itself sometimes ends up being a train-wreck of hype too. More recently...
by rss feed | Jan 5, 2021 | Camillo Ricordi, COVID-19, MSCs Mesenchymal stem stromal cells, News Feeds, Stem cells for COVID-19, umbilical cord stem cells
A new paper today in Stem Cells Translational Medicine on a small COVID-19 Phase 1/2a trial using an umbilical cord stem cell product reports a surprising degree of possible efficacy. What’s the scoop here and could there be some hype in the media about this new...
by rss feed | Jan 5, 2021 | Camillo Ricordi, COVID-19, MSCs Mesenchymal stem stromal cells, News Feeds, Stem cells for COVID-19, umbilical cord stem cells
A new paper today in Stem Cells Translational Medicine on a small COVID-19 Phase 1/2a trial using an umbilical cord stem cell product reports a surprising degree of possible efficacy. What’s the scoop here and could there be some hype in the media about this new...
by rss feed | Jan 5, 2021 | Camillo Ricordi, COVID-19, MSCs Mesenchymal stem stromal cells, News Feeds, Stem cells for COVID-19, umbilical cord stem cells
A new paper today in Stem Cells Translational Medicine on a small COVID-19 Phase 1/2a trial using an umbilical cord stem cell product reports a surprising degree of possible efficacy. What’s the scoop here and could there be some hype in the media about this new...
by rss feed | Dec 22, 2020 | COVID-19, Mesoblast, News Feeds, Remestemcel-l, stem cell clinical trials, Stem cells for COVID-19
I’ve been closely following the arena of stem cells for COVID-19 since the pandemic broke including the efforts of Mesoblast. Mesoblast unlikely to meet primary endpoints in Phase III COVID trial Now, the firm got bad news as its DSMB reported that they are...
